Mithra Pharmaceuticals S.A.

MITPFOTCHealthcare

$23.90

+$17.15(+254.07%)

Market Cap$1.6B

P/E Ratio—

52W High$23.9

52W Low$6.75

Avg Volume285.34673

Open$6.75

Beta0.60

Cash on Hand Financials Revenue

Mithra Pharmaceuticals S.A. (MITPF) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

MITPF · cash on hand · updated Dec 31, 2023

Core cash position

as of Dec 31, 2023

Cash & Short-Term Investments (CCE + ST Investments)

$9.0M▼ -68.3% vs prior year

FY · as of Dec 31, 2023 · Reported in EUR

Cash & Cash Equiv. (CCE)

$9.0M

cashAndCashEquivalents

Short-Term Investments

shortTermInvestments

YoY Change vs Prior Year

-68.3%

vs prior fiscal year

Latest Quarter

$9.0M

Q4 2023

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in EUR

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2023

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$9.0MCash on Hand

Total Debt$212.3MTotal Debt

Net Cash / Net Debt−$203.3MNet Debt Position

Cash vs Debt Ratio

Cash 4%Mithra Pharmaceuticals S.A. cash as % of market cap: 0.56%% · MCap $2BDebt 96%

Mithra Pharmaceuticals S.A. carries a net debt position of $203.3M. Total debt ($212.3M) exceeds cash on hand ($9.0M). Mithra Pharmaceuticals S.A. cash vs debt ratio: 4% cash / 96% debt.

Net Cash = Cash & ST Investments − Total Debt$9.0M − $212.3M = −$203.3M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

MITPF annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

MITPF cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2023LatestFY$9.0M-68.3%

Dec 31, 2022FY$28.3M-14.0%

Dec 31, 2021FY$32.9M-76.3%

Dec 31, 2020FY$138.7M+178.7%

Dec 31, 2019FY$49.8M-58.2%

MITPF cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

MITPF vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Mithra Pharmaceuticals S.A.YOU

MITPF

$9.0M$2B0.6%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Mithra Pharmaceuticals S.A. (MITPF) cash on hand as of December 31, 2023 is $9.0M, comprising $9.0M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Mithra Pharmaceuticals S.A. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Mithra Pharmaceuticals S.A. cash reserves or cash position.

Mithra Pharmaceuticals S.A. annual cash on hand history shows decreased -68.3% in 2023: decreased -68.3% in 2023. Mithra Pharmaceuticals S.A. cash reserves in 2023 reflect the company's capital allocation strategy.

Mithra Pharmaceuticals S.A. carries total debt of $212.3M against cash of $9.0M, resulting in a net debt position of -$203.3M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

MITPF cash on hand · 5 questions

As of December 31, 2023, Mithra Pharmaceuticals S.A. (MITPF) has $8,980,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $8,980,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (December 31, 2023): $8,980,000. Data sourced from the annual 10-K filing via FMP.

MITPF cash on handMITPF cash reservesMITPF cash 2023how much cash does MITPF have

▸ Source: FMP /balance-sheet-statement · US GAAP · Mithra Pharmaceuticals S.A. · Mithra Pharmaceuticals S.A. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2023